WELLINGTON MANAGEMENT CO LLP 13D and 13G filings for Amedisys, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-08 10:18 am Sale |
2023-12-29 | 13G | Amedisys, Inc. AMED |
WELLINGTON MANAGEMENT CO LLP | 24 0.000% |
-2,802,807 (-100.00%) |
Filing |
| 2023-02-06 2:59 pm Purchase |
2022-12-30 | 13G | Amedisys, Inc. AMED |
WELLINGTON MANAGEMENT CO LLP | 2,802,831 8.630% |
990,420 (+54.65%) |
Filing |
| 2022-02-04 09:26 am Sale |
2021-12-31 | 13G | Amedisys, Inc. AMED |
WELLINGTON MANAGEMENT CO LLP | 1,812,411 5.560% |
-633,084 (-25.89%) |
Filing |
| 2021-02-04 11:00 am Purchase |
2020-12-31 | 13G | Amedisys, Inc. AMED |
WELLINGTON MANAGEMENT CO LLP | 2,445,495 7.450% |
2,445,495 (New Position) |
Filing |